[go: up one dir, main page]

IL233878A0 - Inhalable liquid formulations of dnase i - Google Patents

Inhalable liquid formulations of dnase i

Info

Publication number
IL233878A0
IL233878A0 IL233878A IL23387814A IL233878A0 IL 233878 A0 IL233878 A0 IL 233878A0 IL 233878 A IL233878 A IL 233878A IL 23387814 A IL23387814 A IL 23387814A IL 233878 A0 IL233878 A0 IL 233878A0
Authority
IL
Israel
Prior art keywords
dnase
liquid formulations
inhalable liquid
inhalable
formulations
Prior art date
Application number
IL233878A
Other languages
Hebrew (he)
Original Assignee
Yoseph Shaaltiel
Avidor Shulman
Protalix Ltd
Uri Hanania
Liat Fux
Tali Kizhner
Yulia Matiuhin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2013/050096 external-priority patent/WO2013114373A1/en
Application filed by Yoseph Shaaltiel, Avidor Shulman, Protalix Ltd, Uri Hanania, Liat Fux, Tali Kizhner, Yulia Matiuhin filed Critical Yoseph Shaaltiel
Priority to IL233878A priority Critical patent/IL233878A0/en
Publication of IL233878A0 publication Critical patent/IL233878A0/en

Links

IL233878A 2012-02-01 2014-07-30 Inhalable liquid formulations of dnase i IL233878A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL233878A IL233878A0 (en) 2012-02-01 2014-07-30 Inhalable liquid formulations of dnase i

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261593676P 2012-02-01 2012-02-01
US201261593350P 2012-02-01 2012-02-01
US201261593788P 2012-02-01 2012-02-01
PCT/IL2013/050096 WO2013114373A1 (en) 2012-02-01 2013-01-31 Inhalable liquid formulations of dnase i
IL233878A IL233878A0 (en) 2012-02-01 2014-07-30 Inhalable liquid formulations of dnase i

Publications (1)

Publication Number Publication Date
IL233878A0 true IL233878A0 (en) 2014-09-30

Family

ID=51691307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233878A IL233878A0 (en) 2012-02-01 2014-07-30 Inhalable liquid formulations of dnase i

Country Status (1)

Country Link
IL (1) IL233878A0 (en)

Similar Documents

Publication Publication Date Title
ZA201703992B (en) Inhalable pharmaceutical compositions
ZA201501847B (en) Formulations of enzalutamide
SG11201502343RA (en) Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
ZA201502503B (en) Hppd variants and methods of use
SG10201609940RA (en) Compounds and their methods of use
SI2854768T1 (en) Pharmaceutical compositions of pemetrexed
ZA201406082B (en) Use of ccr3-inhibitors
PT2827862T (en) Formulations of bendamustine
PL2934134T3 (en) Uses of acetylsalocylic acid inhalation
GB201501016D0 (en) Preparation of 18F-fluciclovine
IL239245A0 (en) New use of aclidinium
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
IL233878A0 (en) Inhalable liquid formulations of dnase i
PL2831210T3 (en) Use of an aliphatic polyether
EP2863894A4 (en) FORMULATION OF FENOFIBRATE
EP2863890A4 (en) FORMULATION OF FENOFIBRATE
IL233879A0 (en) Drypowder formulations of dnase i
GB201104632D0 (en) Use of medicament
TWM433525U (en) Structure of calorifier

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed